Skip to main content
. 2023 Mar 1;24(5):4772. doi: 10.3390/ijms24054772
5-HT 5-hydroxytryptamine (serotonin)
ADRs adverse drug reactions
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (glutamate receptors)
BDNF brain derived neurotrophic factor
CNS central nervous system
COX-2 cyclooxygenase 2
GABA gamma aminobutyric acid
HPA hypothalamic-pituitary-axis
SSRIs selective serotonin reuptake inhibitors
Il interleukin
INF-γ interferon-γ
iNOS inducible nitric oxide synthase
MAH marketing authorization holder
MAOIs monoamine oxidase inhibitors
MDD major depressive disorder
NDRIs noradrenaline and dopamine reuptake inhibitors
NE noradrenaline (norepinephrine)
NF-κB nuclear factor-kappa factor
NMDA N-methyl-D-aspartate (glutamate receptors)
NRIs noradrenaline reuptake inhibitors
OTC over the counter (drugs)
OS oxidative stress
SNRIs selective noradrenaline reuptake inhibitors
SJW St. John’s wort
TCAs tricyclic antidepressants
TNF-α tumour necrosis alpha
WHO World Health Organization